AV-1015

N/A

Report date: 2026/01/09 10:17:41
NME

Base Information

Drug NameAV-1015
Drug Alias NameAV-1015AV1015
ClassificationSmall molecules
Mechanisms of ActionLymphocyte differentiation antigen CD38 inhibitors
TargetsLymphocyte differentiation antigen CD38
Therapy Area/IndicationsBecker muscular dystrophyObesityMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAeovian Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAeovian Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsBecker muscular dystrophyObesityMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A